Astrazeneca PLC ORD SHS $0.25
Astrazeneca PLC ORD SHS $0.25/ GB0009895292 /
AZN
2024. 05. 10. 17:51:25
|
Vált.
-
|
Forgalom (db) |
Vétel6:00:06 |
Eladás6:00:06 |
Piaci kapitalizáció |
Osztalékh. |
P/E Ráta |
12 370,0000GBX
|
-
|
1,41 mill. Forgalom(GBP): 124,29 mill. |
11 500,0000Vétel (db): 4 000 |
12 470,0000Eladás (db): 500 |
191,74 mrd.GBP |
- |
- |
Cégbemutató
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Igazgatóság & Felügyelőbizottság
CEO |
Pascal Soriot |
Igazgatóság |
Aradhana Sarin, Pam Cheng, Ruud Dobber, Marc Dunoyer, David Fredrickson, Susan Galbraith, Menelas (Mene) Pangalos, Jeff Pott, Iskra Reic, Leon Wang, Sharon Barr |
Felügyelőbizottság |
Michel Demaré, Pascal Soriot, Aradhana Sarin, Philip Broadley, Euan Ashley, Deborah DiSanzo, Diana Layfield, Sheri McCoy, Tony Mok, Nazneen Rahman, Andreas Rummelt, Marcus Wallenberg |